Basic information
- CAS
1246751-68-7- Standard SMILES
CC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NC12CC3CC(C1)CC(C(N)=O)(C3)C2- InChIKey
LUJZBZPLIRWWGJ-ZKHAZHQOSA-N- Molecular formula
- C27H42N6O8
- Average molar mass
- 578.7 g/mol
- Monoisotopic mass
- 578.30641232
Names & identifiers
- Preferred name
- Ac-dggl-adamatanylglycine-NH2
- IUPAC
- (3S)-3-acetamido-4-[[2-[[2-[[(2S)-1-[(3-carbamoyl-1-adamantyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid
- English name
- Peptide021(P021)
- Molecular formula
- C27H42N6O8
- Molecular weight
- 578.66
Names & synonyms
Ac-dggl-adamatanylglycine-NH2P-21 nootropic peptideVV8CZC8PASUNII-VV8CZC8PASP-211246751-68-7L-Leucinamide, N-acetyl-L-alpha-aspartylglycylglycyl-N-(3-(aminocarbonyl)tricyclo(3.3.1.13,7)dec-1-yl)-N-Acetyl-L-alpha-aspartylglycylglycyl-N-(3-(aminocarbonyl)tricyclo(3.3.1.13,7)dec-1-yl)-L-leucinamideL-LEUCINAMIDE, N-ACETYL-L-.ALPHA.-ASPARTYLGLYCYLGLYCYL-N-(3-(AMINOCARBONYL)TRICYCLO(3.3.1.13,7)DEC-1-YL)-N-ACETYL-L-.ALPHA.-ASPARTYLGLYCYLGLYCYL-N-(3-(AMINOCARBONYL)TRICYCLO(3.3.1.13,7)DEC-1-YL)-L-LEUCINAMIDEP21 (P021)Peptide021(P021)
Show more names
L-Leucinamide P21 PeptidesL-Leucinamide, N-acetyl-L-α-aspartylglycylglycyl-N-[3-(aminocarbonyl)tricyclo[3.3.1.13,7]dec-1-yl]-
Database identifiers
Properties
Computed structural properties
- XLogP
- -1.1
- Topological polar surface area
- 226 Ų
- Hydrogen bond donors
- 7
- Hydrogen bond acceptors
- 8
- Rotatable bonds
- 14
- Heavy atoms
- 41
- Formal charge
- 0
- Complexity
- 1,080
Physicochemical properties
- Boiling point
- 1061.4 · 1061.4±65.0 °C(Predicted)
- Density
- 1.33 · 1.33±0.1 g/cm3(Predicted)
- pka
- 4.23 · 4.23±0.10(Predicted)
- InChIKey
- ZBTMPXAMODQBPM-ZKHAZHQOSA-N
- SMILES
- C(N)(=O)[C@H](CC(C)C)N(C(=O)CNC(=O)CNC(=O)[C@H](CC(O)=O)NC(C)=O)C12CC3CC(CC(C(N)=O)(C3)C1)C2
- FDA UNII
- 8 CZC8PAS · VV8CZC8PAS
Chemistry & industry
Applications
UsesDerived from amino acids 139–164 of the C-terminus of the full-length p21 protein, the Peptide021(P021) interferes with proliferating cell nuclear antigen (PCNA) function and lacks organized structure in its free form[1][2]. The p21C2 peptide serves as a precursor to analyze whether S phase is inhibited by microinjection[1].
Suppliers18 total
陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
武汉敬康恩生物医药科技有限公司13720134139 086-15871494362 13720134139 · [email protected]
武汉科杰峰贸易有限公司18827003015 · [email protected]
上海尺水药物研究有限公司[email protected] 13564957716 · [email protected]
NANJING YINGWEN BIOTECHNOLOGY CO LTD+8613382787392 · [email protected]
杭州贝普泰生物医药有限公司0571-85350119 13305819357 · [email protected]
珀尔生物科技（聊城市）有限公司17763511183 · [email protected]
杭州固拓生物科技有限公司0571-88211921 17357109671 · [email protected]
石家庄瑞田生化有限公司15831127780 · [email protected]
成都云希化工有限公司+86-17380623303 · [email protected]
Yiwu Qitai Trading Co., Ltd.+8619133399954 · [email protected]
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…